Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Polatuzumab Vedotin
High Grade B-Cell Lymphoma
Brown UniversityP2B (59)
Pyrotinib
Gastric Cancer
BeOne MedicinesP2B (59)
Regramostim
Prostate Cancer
University of Wisconsin, MadisonP2B (59)
Relatlimab
Hepatocellular Carcinoma
Bristol-Myers SquibbP2B (59)
Revumenib
Acute Leukemia Of Ambiguous Lineage
SWOG Cancer Research NetworkP2B (59)
Revumenib
Mixed Phenotype Acute Leukemia
Children's Oncology GroupP2B (59)
Riluzole
Cutaneous Melanoma
National Cancer Institute (NCI)P2B (59)
Rituximab
Idiopathic Pulmonary Fibrosis
University of Alabama at BirminghamP2B (59)
Rituximab
Small Cell Lung Carcinoma
Puma Biotechnology, Inc.P2B (59)
Ruxolitinib
Adult T-Cell Leukemia/Lymphoma
Jonathan BrammerP2B (59)
Ruxolitinib
Hematopoietic And Lymphoid System Neoplasm
Stanford UniversityP2B (59)
Ruxolitinib
Non-Hodgkin Lymphoma
Seda S. ToluP2B (59)
Ruxolitinib
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
St. Petersburg State Pavlov Medical UniversityP2B (59)
Ruxolitinib
Myelofibrosis
Center for International Blood and Marrow Transplant ResearchP2B (59)
Ruxolitinib
T-Cell Non-Hodgkin Lymphoma
Jonathan BrammerP2B (59)
Ruxolitinib
T-Cell Prolymphocytic Leukemia
Jonathan BrammerP2B (59)
Sirolimus
Chronic Myelomonocytic Leukemia
City of Hope Medical CenterP2B (59)
Sirolimus
Epilepsy
Xuanwu Hospital, BeijingP2B (59)
Sirolimus
Myelofibrosis
Masonic Cancer Center, University of MinnesotaP2B (59)
Sirolimus
Sickle Cell Disease
St. Jude Children's Research HospitalP2B (59)
Tafasitamab
High Grade B-Cell Lymphoma
Brown UniversityP2B (59)
Tafasitamab
Non-Hodgkin Lymphoma
Paolo Caimi, MDP2B (59)
Talazoparib
Refractory Malignant Neoplasm
St. Jude Children's Research HospitalP2B (59)
Talazoparib
Gastric Cancer
National Cancer Institute (NCI)P2B (59)
Talazoparib
Small Cell Lung Carcinoma
University Health Network, TorontoP2B (59)
Showing 2426 to 2450 of 13,155 assets
PreviousPage 98 of 527Next